SCHEMBL5042415

SCHEMBL5042415

COC(C(=O)O)c1c(O)cccc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
GAA P10253 1/20 0.44
CA12 O43570 3/20 0.39
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA7 P43166 3/20 0.39
CA9 Q16790 3/20 0.39
CA14 Q9ULX7 3/20 0.39
CES2 O00748 2/20 0.39
CES1 P23141 2/20 0.39
KDM4E B2RXH2 1/20 0.38
ALB P02768 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
PDE4D Q08499 1/20 0.35
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
FABP4 P15090 1/20 0.33
FABP5 Q01469 1/20 0.33
THRB P10828 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2352769 0.90 ALDH1A1 (0.49) ALDH1A1GAACES2CES1KDM4E
SCHEMBL5040787 0.82 CA12 (0.44) ALDH1A1GAACA12CA1CA2
SCHEMBL5041042 0.80 ALDH1A1 (0.38) ALDH1A1GAAKDM4EL3MBTL1TSHR
SCHEMBL2349656 0.75 CES2 (0.46) ALDH1A1GAACES2CES1KDM4E
SCHEMBL5042075 0.74 MRGPRX4 (0.50) ALDH1A1KDM4EL3MBTL1LMNAFABP4
SCHEMBL5037418 0.74 ALDH1A1 (0.51) ALDH1A1GAACES2CES1KDM4E
SCHEMBL17724548 0.74 ALDH1A1 (0.51) ALDH1A1GAACES2CES1KDM4E
SCHEMBL11256694 0.72 FABP4 (0.48) ALDH1A1KDM4EL3MBTL1LMNATSHR
SCHEMBL27798053 0.72 CES2 (0.43) ALDH1A1CA12CA1CA2CA7
Hydrochloric Acid SCHEMBL11250887 0.70 FABP4 (0.47) ALDH1A1KDM4EL3MBTL1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 ALDH1A1 519/4885GAA 1312/4885CA12 1647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.